Skip to main content

This site is intended for US residents.

OJEMDA (tovorafenib) logo: 100 mg tablets 25 mg/mL for oral suspension

Holmes, lives with pLGG, and Clare, Holmes' mom

Safety and side effects

OJEMDA was generally well tolerated in the clinical study

When the results of the FIREFLY-1 study were reviewed,

74%

of children were still taking OJEMDA

(102 out of 137)

93%

of children did not stop taking OJEMDA due to side effects

(128 out of 137)

The main side effects that caused 7% of children (9 out of 137) to stop taking OJEMDA were:

If your child experiences any serious side effects during treatment with OJEMDA, your child’s doctor may decrease dosage, pause treatment, or stop treatment.

The FIREFLY-1 main phase concluded at the end of 2024. Patients are being followed for longer-term observation.

Hear from caregivers about how they worked with their care teams to manage side effects for their children taking OJEMDA



Side effects can happen with any medication. It is important to discuss any symptoms your child may experience while taking OJEMDA so that your doctor can advise on the appropriate course of action.

Dr Peter Manley, Vice President, Clinical Development, at Day One Biopharmaceuticals


What are the possible side effects?

OJEMDA may cause serious side effects, including

Bleeding problems,

such as nose bleeds or bleeding from the tumor

Call your child’s doctor immediately if they have any symptoms, including:

  • Headache, dizziness, or feeling weak
  • Coughing up blood or blood clots
  • Vomiting blood or vomit looks like coffee grounds
  • Red or black stools that look like tar

Skin reactions, including sensitivity to sunlight (photosensitivity)

Call your child’s doctor if your child gets new or worsening skin reactions, including:

  • Rash
  • Bumps
  • Acne
  • Peeling, redness, or irritation
  • Blisters

Liver problems

Your child’s doctor will do blood tests to check your child’s liver function before and during treatment with OJEMDA. Call your child’s doctor right away if your child gets any of the following symptoms:

  • Yellowing of skin or eyes
  • Dark or brown (tea-colored) urine
  • Nausea or vomiting
  • Loss of appetite
  • Tiredness
  • Bruising
  • Bleeding
  • Pain in the upper right stomach area

Slowing of growth (height)

  • Your child’s growth will be checked routinely during treatment with OJEMDA
  • Rate of growth resumed after children took a break from OJEMDA

Other safety considerations

OJEMDA may cause fertility problems in female and male children, which can affect their ability to have children. If you have concerns about your child’s fertility, you should discuss their family planning goals with their care team. Remember, your care team is there to support you every step of the way.

What are the most common side effects?

The 137 children in the clinical study mostly experienced mild to moderate side effects while taking OJEMDA. Talk to your child’s care team right away if they experience any side effects, and discuss ways to manage them.

Out of 137 children, what percent experienced it?

Rash

77%

Hair color changes

76%

Fatigue (tiredness)

55%

Viral infection

55%

Vomiting

50%

Headache

45%

Fever

39%

Dry skin

36%

Constipation

33%

Nausea

33%

Acne

31%

Upper respiratory tract infection

31%

These are not all the possible side effects with OJEMDA. Talk to your child’s care team for medical advice about possible side effects.


You may report side effects to the FDA at 1-800-FDA-1088.

You may also report side effects to Day One Biopharmaceuticals at 1-877-204-2820.

IMPORTANT SAFETY
INFORMATION

Before taking or giving OJEMDA, tell your healthcare provider about all of your or your child’s medical conditions, including if you:

  • have bleeding, skin, or liver problems
  • are pregnant or plan to become pregnant. OJEMDA can harm your unborn baby.

Females who are able to become pregnant:

  • You should use effective non-hormonal birth control (contraception) during treatment with OJEMDA and for 28 days after your last dose of OJEMDA.

Males with female partners who are able to become pregnant should use effective non-hormonal birth control (contraception) during treatment with OJEMDA and for 2 weeks after your last dose of OJEMDA.

  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 2 weeks after your last dose of OJEMDA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What should I avoid while taking OJEMDA?

Limit the amount of time you spend in sunlight. OJEMDA can make your skin sensitive to the sun (photosensitivity). Use sun protection measures, such as sunscreen, sunglasses and wear protective clothes that cover your skin during your treatment with OJEMDA.

What are the possible side effects of OJEMDA?

OJEMDA may cause serious side effects, including:

  • bleeding problems (hemorrhage) are common and can also be serious. Tell your healthcare provider if you develop any signs or symptoms of bleeding, including:
    • headache, dizziness or feeling weak
    • coughing up blood or blood clots
    • vomiting blood or your vomit looks like "coffee grounds"
    • red or black stools that look like tar
  • skin reactions, including sensitivity to sunlight (photosensitivity). OJEMDA can cause skin reactions that can become severe. Tell your healthcare provider if you get new or worsening skin reactions, including:
    • rash
    • bumps or tiny papules
    • acne
    • peeling, redness, or irritation
    • blisters
  • liver problems. Your healthcare provider will do blood tests to check your liver function before and during treatment with OJEMDA. Tell your healthcare provider right away if you develop any of the following symptoms:
    • yellowing of your skin or your eyes
    • dark or brown (tea-colored) urine
    • nausea or vomiting
    • loss of appetite
    • tiredness
    • bruising
    • bleeding
    • pain in your upper right stomach area
  • slowed growth in children. Growth will be checked routinely during treatment with OJEMDA.

The most common side effects of OJEMDA include:

  • rash
  • hair color changes
  • tiredness
  • viral infection
  • vomiting
  • headache
  • fever
  • dry skin
  • constipation
  • nausea
  • acne
  • upper respiratory tract infection

OJEMDA may cause fertility problems in males and females, which may affect your ability to have children.

These are not all the possible side effects of OJEMDA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Patient Information, including Instructions for Use, for more information.

INDICATION

What is OJEMDA™ (tovorafenib)?

OJEMDA is a prescription medicine used to treat certain types of brain tumors (cancers) called gliomas in patients 6 months and older:

  • that is a pediatric low-grade glioma (LGG), and
  • that has come back after previous treatment or has not responded to previous treatment and
  • that has a certain type of abnormal “BRAF” gene.